US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

45.97

+0.26860.59%

Post-market: 45.51-0.4564-0.99%16:15 EDT

Volume:2K

Turnover:106.96K

Market Cap:126.73M

PE:- -

High:46.65

Open:46.65

Low:45.51

Close:45.70

52wk High:48.78

52wk Low:27.68

Shares:2.76M

Float Shares:2.76M

Volume Ratio:0.85

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

United Therapeutics Q2 Revenue Misses Estimates on Ebulized Tyvaso Weakness

LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance

LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

LivaNova Says Cardiopulmonary President Stefano Folli Files Initial Beneficial Ownership Statement

LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1

LivaNova Q2 Adj. EPS $1.26 Beats $1.10 Estimate, Sales $390.600M Beat $380.758M Estimate

Benzinga Earnings

LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand

THOMSON REUTERS

LivaNova Outlook FY Revenue Growth 8-9%

THOMSON REUTERS

LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million

THOMSON REUTERS

LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply

THOMSON REUTERS

LivaNova Plc: Announce Agreement with Thermo Fisher Scientific

THOMSON REUTERS

Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

Travere Therapeutics, Inc. : Jefferies Raises Target Price to $64 from $54

THOMSON REUTERS

Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On

Benzinga Earnings

Travere Therapeutics, Inc. : TD Cowen Raises Target Price to $75 from $60

THOMSON REUTERS

Spyre Therapeutics Inc : Jefferies Raises Target Price to $122 from $98

THOMSON REUTERS

Travere Therapeutics, Inc. : Guggenheim Raises Target Price to $75 from $65

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top Healthcare Picks

Spyre Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/LFSC/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":45.9664,"timestamp":1788379200000,"preClose":45.6978,"halted":0,"volume":2330,"hourTrading":{"tag":"盘后","latestPrice":45.51,"preClose":45.9664,"latestTime":"16:15 EDT","volume":10,"amount":459.664,"timestamp":1788380100276,"change":-0.4564,"changeRate":-0.009929,"amplitude":0},"delay":0,"changeRate":0.005877744661668598,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Closed","change":0.2686,"latestTime":"09-02 16:00:00 EDT","open":46.65,"high":46.65,"low":45.51,"amount":106959,"amplitude":0.024946,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":45.6978,"sharesOutstanding":2657035,"nav":45.72,"aum":126051640.2,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":45.51,"preClose":45.9664,"latestTime":"16:15 EDT","volume":10,"amount":459.664,"timestamp":1788380100276,"change":-0.4564,"changeRate":-0.009929,"amplitude":0},"volumeRatio":0.854983},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.854983,"shares":2757035,"dividePrice":0,"high":46.65,"amplitude":0.024946,"preClose":45.6978,"low":45.51,"week52Low":27.6794,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":45.9664,"eps":0,"divideRate":0,"volume":2330,"delay":0,"ttmEps":0,"open":46.65,"prevYearClose":36.6147,"prevWeekClose":45.9566,"prevMonthClose":45.79,"prevQuarterClose":45.2033,"fiveDayClose":47.5848,"twentyDayClose":47.4383,"sixtyDayClose":37.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657543991","title":"United Therapeutics Q2 Revenue Misses Estimates on Ebulized Tyvaso Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2657543991","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657543991?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:38","pubTimestamp":1785926324,"startTime":"0","endTime":"0","summary":"United Therapeutics Q2 revenue misses estimates on Ebulized Tyvaso weaknessOverviewRare disease drugmaker's Q2 revenue fell 2% yr/yr, missing analyst expectationsQ2 net income rose 8% yr/yr; diluted E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","HELX","PSCH","LU1699723380.USD","KRYS","TVTX","UTHR","BK4139","LFSC","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548787","title":"LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548787","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548787?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:17","pubTimestamp":1785925061,"startTime":"0","endTime":"0","summary":"LivaNova’s Q2 2026 revenue rose 10.8% to $390.6 million, while GAAP diluted EPS increased to $1.93 from $0.50 and adjusted diluted EPS reached $1.26. Cardiopulmonary and Neuromodulation each posted double-digit reported growth. The company raised constant-currency revenue growth guidance to 8%-9% and adjusted EPS guidance to $4.30-$4.40, but reduced adjusted free cash flow guidance to $140-$160 million. A $95.4 million discrete tax benefit materially boosted GAAP net income, while adjusted operating margin improved to 23.2% from 21.9%.","market":"nz","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock10.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock10.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262077133-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIVN","LU2065170008.USD","LU2065171311.SGD","QLTY","MCOW","ABLG","CAFG","LU2065169927.USD","SYLD","BK4588","SFLO","LCOW","DIVB","NQLT","SCOW","ABLS","COWG","QFRD","FQAL","CALF","DSMC","BK4082","COWZ","DFNV","SPHQ","QUAL","BK4585","ABFL","ICOW","LU2065171402.SGD","LFSC","MOTG","PKW","LGCF","TPFC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657548533","title":"LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657548533","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657548533?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:13","pubTimestamp":1785924796,"startTime":"0","endTime":"0","summary":"LivaNova Q2 FY26 GAAP diluted EPS rises to $1.93; revenue increases 10.8% year over year to $390.6 millionLivaNova posted Q2 revenue of $390.6 million, up 10.8% from a year earlier; U.S. GAAP diluted ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDLyk5Bh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","BK4535","LU2357305700.SGD","LIVN","LU1854103824.USD","LU0234572021.USD","LU2089984988.USD","TMO","LU2092937221.SGD","LU2125909247.SGD","IE00B4R5TH58.HKD","LU0882574055.USD","LU1989771016.USD","LU2112291526.USD","LFSC","IE0002141913.USD","LU0114720955.EUR","LU0957791311.USD","HRTS","GB00BDT5M118.USD","LU1988902786.USD","BK4534","IE0034235188.USD","LU2298321311.HKD","LU0122379950.USD","LU0011850046.USD","TMED","GNMX","IE00BKPKM429.USD","LU0061474960.USD","LU0640476718.USD","LU2065169927.USD","IE00BJJMRZ35.SGD","LU0528227936.USD","LU0208291251.USD","IE00B19Z9505.USD","LU1623119135.USD","LU2125909593.SGD","FMED","LU1670628061.USD","LU2764262908.HKD","LU1153585028.USD","LU2764263203.CNY","LU2211815571.USD","LU0316494557.USD","LU0070302665.USD","LU1923622291.USD","LU2764263039.SGD","LU1720051017.SGD","LU1815333072.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654837","title":"UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654837","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657654837?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:11","pubTimestamp":1785924675,"startTime":"0","endTime":"0","summary":"UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlookOverviewUK medical technology firm's Q2 revenue grew 10.8%, beating analyst expectationsAdjusted EPS for Q2 beat analyst expectationsCompany","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420EB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","GNMX","BK4581","LU2211815571.USD","MADE","BK4082","LU0345770993.USD","LU2463526074.USD","LU0528227936.USD","IE00BQXX3F31.USD","IE000M9KFDE8.USD","TMED","IE0002141913.USD","LIVN","LU0320765489.SGD","BK4585","LU0096362180.USD","HRTS","LU2720916845.USD","IE0034235188.USD","LU1815333072.USD","LU1064131342.USD","LU1815336091.USD","LU1791710400.SGD","LU1169589451.USD","LU0057025933.USD","LU0203347892.USD","ITGR","LU2360108059.USD","LU0342679015.USD","TMO","LU2041044095.USD","CLPT","IE00BKPKM429.USD","LFSC","LU1803068623.USD","LU0061474960.USD","IE00B19Z8X17.USD","LU0114720955.EUR","LU2125909916.SGD","IE00B4R5TH58.HKD","LU0566484027.USD","CMI","FMED","LU0266013472.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1559883803.SGD","LU2468319806.SGD","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657751001","title":"LivaNova Says Cardiopulmonary President Stefano Folli Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657751001","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657751001?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:07","pubTimestamp":1785924478,"startTime":"0","endTime":"0","summary":"LivaNova says Cardiopulmonary President Stefano Folli files initial beneficial ownership statementLivaNova filed an initial ownership report for Stefano Folli, president of cardiopulmonary, showing 6,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL57w5XY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4082","LU2065171311.SGD","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LIVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657104155","title":"LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2657104155","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657104155?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:01","pubTimestamp":1785924061,"startTime":"0","endTime":"0","summary":"BRIEF-LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1Aug 05  - LivaNova Q2 EPS USD 1.93.Q2 revenue USD 390.6 million vs. IBES estimate USD 380.8 millionoutlook FY adjusted EPS USD 4.3-4.4 vs. IBES estimate USD 4.25outlook FY revenue growth 8-9%outlook FY adjusted free cash flow USD 140-160 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","LU2065169927.USD","LIVN","LU2065171402.SGD","LFSC","BK4082","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510969","title":"LivaNova Q2 Adj. EPS $1.26 Beats $1.10 Estimate, Sales $390.600M Beat $380.758M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510969","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510969?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924054,"startTime":"0","endTime":"0","summary":"LivaNova (NASDAQ:LIVN) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.10 by 14.55 percent. This is a 20 percent increase over earnings of $1.05 per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60939804/livanova-q2-adj-eps-1-26-beats-1-10-estimate-sales-390-600m-beat-380-758m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","BK4082","LU2065171311.SGD","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","LIVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657881548","title":"LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657881548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657881548?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2125909759.SGD","LFSC","IE00B19Z8X17.USD","LU2264538146.SGD","LU2211815571.USD","GNMX","LU2089984988.USD","LU0342679015.USD","BK4533","LU0208291251.USD","LU1633808545.USD","LU2211814178.USD","LU1023059063.AUD","LU1670628061.USD","LU2125910336.SGD","LU2468319806.SGD","LU1803068623.USD","LU0070302665.USD","LU1791710582.SGD","LU1548497426.USD","LU2357305700.SGD","FMED","LU2360108059.USD","LU0096362180.USD","LU1291159041.SGD","IE0002141913.USD","LU0316494557.USD","LU0432979614.USD","LU0528227936.USD","LU1983299246.USD","LU2764262908.HKD","LU1153585028.USD","TMED","LU1712237335.SGD","LU0345770308.USD","HRTS","BK4581","LU2298321311.HKD","LIVN","TMO","LU1923621640.USD","LU0557290698.USD","LU1064131342.USD","LU0011850046.USD","LU0114720955.EUR","LU1988902786.USD","IE00B19Z8W00.USD","IE00B1BXHZ80.USD","LU2065169927.USD","IE00B19Z9505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510990","title":"LivaNova Outlook FY Revenue Growth 8-9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510990","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510990?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LIVN","LFSC","LU2065169927.USD","LU2065170008.USD","LU2065171311.SGD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510191","title":"LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510191?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LU2065171402.SGD","LFSC","LU2065170008.USD","LU2065171311.SGD","LIVN","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510022","title":"LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510022?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1153585028.USD","LU1023059063.AUD","LU1720051108.HKD","LU2543165471.USD","LU1720051017.SGD","LFSC","LU1803068623.USD","LU1923622614.USD","LU0011850046.USD","LU2065170008.USD","LU2089984988.USD","LU2360108059.USD","TMO","LU2264538146.SGD","LU2063271972.USD","IE00B2B36J28.USD","LU1712237335.SGD","LU2433249047.HKD","LU0061474960.USD","BK4533","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1633808545.USD","LU2125909916.SGD","LU2764263039.SGD","LU0528227936.USD","BK4585","LU1623119135.USD","IE0034235188.USD","LU2468319806.SGD","LU1291159041.SGD","LU0345770993.USD","GNMX","LU2764262908.HKD","LU0823416689.USD","BK4082","IE00BFTCPJ56.SGD","HRTS","LU1983299246.USD","IE00BQXX3D17.EUR","LU1989771016.USD","TMED","LU1057294990.SGD","LIVN","FMED","LU1854104046.USD","LU1854103824.USD","LU1064131342.USD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657013510","title":"LivaNova Plc: Announce Agreement with Thermo Fisher Scientific","url":"https://stock-news.laohu8.com/highlight/detail?id=2657013510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657013510?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nPLX8HZ676:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","LU2065169927.USD","LU1815333072.USD","IE00BJJMRZ35.SGD","LU2092937221.SGD","LU2112291526.USD","GNMX","LU0114720955.EUR","LU0316494557.USD","LU2764262908.HKD","IE0034235188.USD","IE00BQXX3C00.GBP","LU1623119135.USD","IE0002141913.USD","LU1670628061.USD","TMO","LU0882574055.USD","LU0070302665.USD","LU0640476718.USD","LU2125909593.SGD","FMED","LU0234572021.USD","LU2298321311.HKD","LU0957791311.USD","GB00BDT5M118.USD","LU1989771016.USD","LU1720051017.SGD","BK4535","IE00B4R5TH58.HKD","HRTS","IE00BKPKM429.USD","LU1923622291.USD","LU1153585028.USD","LU1988902786.USD","BK4534","IE00B19Z9505.USD","LU0061474960.USD","LU0528227936.USD","LU1854103824.USD","TMED","LU2764263039.SGD","LU0122379950.USD","LU2357305700.SGD","LU2089984988.USD","LU2211815571.USD","LU2764263203.CNY","LIVN","LU0208291251.USD","LU0011850046.USD","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510573","title":"Press Release: LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510573?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:00","pubTimestamp":1785924000,"startTime":"0","endTime":"0","summary":"-- Delivered double-digit reported revenue growth of 10.8%, with constant-currency revenue growth of 9.8%-- Raised full-year 2026 revenue and adjusted diluted earnings per share guidance-- Entered into a long-term agreement with Thermo Fisher Scientific to strengthen oxygenator component supply to expand manufacturing output and satisfy unmet demandGLOUCESTER, England----August 05, 2026--LivaNova PLC , a market-leading medical technology company, today reported results for the second quarter ended June 30, 2026 and raised full-year 2026 guidance.Financial Summary and Highlights--  Second-quarter revenue of $390.6 million increased 10.8% on a reported. basis and 9.8% on a constant-currency basis as compared to the prior-year. --  Second-quarter U.S. GAAP diluted earnings per share of $1.93 and. --  Second-quarter net cash provided by operating activities of $66.6. million and adjusted free cash flow of $45.5 million. --  Raised full-year 2026 revenue growth range by 100 basis points to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLO","DECU","JOYT","GXDW","LU2065171311.SGD","VOTE","LIVN","VGFPF","LU2065169927.USD","BK4585","03160","BK4588","BK4082","TM","LU2065170008.USD","LFSC","BK4604","LU2065171402.SGD","FEBU","BK4099","BK4555","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657451663","title":"Travere Therapeutics, Inc. : Jefferies Raises Target Price to $64 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2657451663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657451663?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:16","pubTimestamp":1785914203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN442137:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVTX","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657516665","title":"Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On","url":"https://stock-news.laohu8.com/highlight/detail?id=2657516665","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657516665?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:16","pubTimestamp":1785914176,"startTime":"0","endTime":"0","summary":"Travere Therapeutics shares surged 13.44% after hours as strong revenue growth and FILSPARI sales gains outweighed earnings concerns.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/08/60938354/travere-therapeutics-shares-surge-after-hours-on-revenue-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODDZ","FFTY","ODDS","TVTX","BETZ","RSI","BK4139","LFSC","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657977695","title":"Travere Therapeutics, Inc. : TD Cowen Raises Target Price to $75 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2657977695","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657977695?lang=en_us&edition=fundamental","pubTime":"2026-08-05 13:11","pubTimestamp":1785906671,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4420C0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LFSC","TVTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657959733","title":"Spyre Therapeutics Inc : Jefferies Raises Target Price to $122 from $98","url":"https://stock-news.laohu8.com/highlight/detail?id=2657959733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657959733?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:45","pubTimestamp":1785905138,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN442029:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657592054","title":"Travere Therapeutics, Inc. : Guggenheim Raises Target Price to $75 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2657592054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657592054?lang=en_us&edition=fundamental","pubTime":"2026-08-05 12:39","pubTimestamp":1785904752,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN44207D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LFSC","TVTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659121","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659121?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:00","pubTimestamp":1785898840,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Illumina (ILMN) and Travere Therapeutics (TVTX) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-276?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-276?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4548","BK4588","BK4139","LFSC","TVTX","GNOM","ILMN","GNMX","LU0029874061.USD","BK4534","BK4535","BK4121","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567255","title":"Spyre Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567255","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567255?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:21","pubTimestamp":1785878482,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummarySpyre Therapeutics IncSYRE.OQreported a quarterly adjusted loss of 36 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44137O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}